$203.382,00
10% de descuento pagando con Transferencia
Ver más detalles
Descripcion
Indice
Autores
Muestra
Ficha Técnica
Descripción

In this issue of Clinics in Chest Medicine, guest editors Drs. Scott Evans, Guang-Shing Cheng, Julio Ramirez, and Bashar Staitieh bring their considerable expertise to the topic of Pulmonary Disease in the Immunocompromised Host. Top experts discuss imaging the immunocompromised lung; laboratory molecular testing in immunocompromised host pneumonia; vaccines and other preventative strategies for immunocompromised pneumonia; adjunctive/host-directed therapies in immunocompromised host pneumonia; sequelae of immunocompromised host pneumonia; and more.

  • Contains 16 relevant, practice-oriented topics including COVID-19 and emerging lung infections in the immunocompromised patient; pulmonary immunocompromise in stem cell transplantation and cellular therapy; pulmonary immunocompromise in solid organ transplantation; pulmonary immunocompromise in chronic and high dose steroid therapy; and more.
  • Provides in-depth clinical reviews on pulmonary disease in the immunocompromised host, offering actionable insights for clinical practice.
  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Algorithmic Approach to an Abnormal Computed Tomography of the Chest in the Immunocompromised Host - p. 1 9. Vaccines and Other Preventative Strategies for Immunocompromised Pneumonia - p. 21 10. Host-Directed Adjunctive Therapies in Immunocompromised Patients with Pneumonia - p. 37 11. Sequelae of Immunocompromised Host Pneumonia - p. 49 12. Evaluation of Inborn Errors of Immunity Among Patients with Opportunistic Pulmonary Infection - p. 61 13. The Microbiome and Pulmonary Immune Function - p. 77 14. Smoking, Alcohol Use, Diabetes Mellitus, and Metabolic Syndrome as Risk Factors for Community-Acquired Pneumonia - p. 93 15. Acute Lung Injury in Immunocompromised Patients - p. 105 16. Pulmonary Complications in Hematologic Malignancies - p. 115 17. Pulmonary Immunocompromise in Stem Cell Transplantation and Cellular Therapy - p. 129 18. Pulmonary Immunocompromise in Solid Organ Transplantation - p. 149 19. Pulmonary Immunocompromise in Chronic and High-dose Steroid Therapy - p. 159 20. Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases - p. 169 21. Pulmonary Immunocompromise in Human Immunodeficiency Virus Disease - p. 185 22. Coronavirus Disease 2019 and Emerging Lung Infections in the Immunocompromised Patient - p. 203

Descripcion
Descripción

In this issue of Clinics in Chest Medicine, guest editors Drs. Scott Evans, Guang-Shing Cheng, Julio Ramirez, and Bashar Staitieh bring their considerable expertise to the topic of Pulmonary Disease in the Immunocompromised Host. Top experts discuss imaging the immunocompromised lung; laboratory molecular testing in immunocompromised host pneumonia; vaccines and other preventative strategies for immunocompromised pneumonia; adjunctive/host-directed therapies in immunocompromised host pneumonia; sequelae of immunocompromised host pneumonia; and more.

  • Contains 16 relevant, practice-oriented topics including COVID-19 and emerging lung infections in the immunocompromised patient; pulmonary immunocompromise in stem cell transplantation and cellular therapy; pulmonary immunocompromise in solid organ transplantation; pulmonary immunocompromise in chronic and high dose steroid therapy; and more.
  • Provides in-depth clinical reviews on pulmonary disease in the immunocompromised host, offering actionable insights for clinical practice.
  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Algorithmic Approach to an Abnormal Computed Tomography of the Chest in the Immunocompromised Host - p. 1 9. Vaccines and Other Preventative Strategies for Immunocompromised Pneumonia - p. 21 10. Host-Directed Adjunctive Therapies in Immunocompromised Patients with Pneumonia - p. 37 11. Sequelae of Immunocompromised Host Pneumonia - p. 49 12. Evaluation of Inborn Errors of Immunity Among Patients with Opportunistic Pulmonary Infection - p. 61 13. The Microbiome and Pulmonary Immune Function - p. 77 14. Smoking, Alcohol Use, Diabetes Mellitus, and Metabolic Syndrome as Risk Factors for Community-Acquired Pneumonia - p. 93 15. Acute Lung Injury in Immunocompromised Patients - p. 105 16. Pulmonary Complications in Hematologic Malignancies - p. 115 17. Pulmonary Immunocompromise in Stem Cell Transplantation and Cellular Therapy - p. 129 18. Pulmonary Immunocompromise in Solid Organ Transplantation - p. 149 19. Pulmonary Immunocompromise in Chronic and High-dose Steroid Therapy - p. 159 20. Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases - p. 169 21. Pulmonary Immunocompromise in Human Immunodeficiency Virus Disease - p. 185 22. Coronavirus Disease 2019 and Emerging Lung Infections in the Immunocompromised Patient - p. 203

Indice
Autores
Muestra
Ficha Técnica